Inventor · disambiguated record
Julia Neugebauer
Also filed as: NEUGEBAUER JULIA
13 granted patents·10 pending applications·47 citations·filing 2009–2024
89Inventor score
Top patents by PatentIndex Score
23 records- 0191US10899841B2Anti-BAFFR antibody formulations and methods of use thereofNOVARTIS AG·Filed 2019·Granted Jan 26, 2021·3 cites·10 claims
- 0290US8106163B2Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2009·Granted Jan 31, 2012·18 cites·13 claims
- 0389US9458240B2Anti-BAFFR antibody formulationsCOSENZA MARTA·Filed 2011·Granted Oct 4, 2016·8 cites·16 claims
- 0487US2025163170A1Antibody formulationNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0584US2025034270A1Compositions and methods of use for therapeutic antibodiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0683US9988455B2Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodiesNOVARTIS AG·Filed 2016·Granted Jun 5, 2018·3 cites·28 claims
- 0782US11254734B2Fab molecules with a rodent hinge region and a non-rodent CH1 regionMORPHOSYS AG·Filed 2017·Granted Feb 22, 2022·2 cites·7 claims
- 0882US9562101B2Lectin-like oxidized LDL receptor 1 antibodies and methods of useHELDWEIN KURT ALEX·Filed 2014·Granted Feb 7, 2017·5 cites·27 claims
- 0981US9340620B2Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2011·Granted May 17, 2016·5 cites·5 claims
- 1077US12018072B2Antibodies specific for human complement C5A receptor (C5AR)MORPHOSYS AG·Filed 2023·Granted Jun 25, 2024·0 cites·30 claims
- 1175US12054555B2Anti-BAFFR antibody formulations and methods of use thereofNOVARTIS AG·Filed 2020·Granted Aug 6, 2024·0 cites·10 claims
- 1274US9382326B2Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2011·Granted Jul 5, 2016·2 cites·10 claims
- 1374US2024400657A1Antibodies targeting c5arMORPHOSYS AG·Filed 2024·Application pending·0 cites
- 1472US11542329B2Antibodies targeting Glycoprotein VIMORPHOSYS AG·Filed 2019·Granted Jan 3, 2023·1 cites·18 claims
- 1572US2022298251A1Compositions and methods of use for therapeutic antibodiesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1669US2018179290A1Antibody formulationNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1764US2022135660A1FAB Molecules with a Rodent Hinge Region and a Non-Rodent CH1 RegionMORPHOSYS AG·Filed 2022·Application pending·0 cites
- 1863US2016368999A1Antibody formulationCOSENZA MARTA·Filed 2016·Application pending·0 cites
- 1960US2019135931A1Compositions and methods of use for therapeutic antibodiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2057US2022135658A1Antibodies targeting c5arMORPHOSYS AG·Filed 2020·Application pending·0 cites
- 2153US11472880B2Humanized antibodies for CD3MORPHOSYS AG·Filed 2018·Granted Oct 18, 2022·0 cites·15 claims
- 2252US2016347851A1Compositions and methods of use for therapeutic antibodiesHEUSSER CHRISTOPH·Filed 2016·Application pending·0 cites
- 2338US9988443B2Angiopoetin-like 4 (ANGPTL4) antibodies and methods of useTRAUGER JOHN·Filed 2015·Granted Jun 5, 2018·0 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Julia Neugebauer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →